Valuation: Edwards Lifesciences Corporation

Market Cap 5.12TCr 4.49TCr 4.22TCr 3.86TCr 7.21TCr 4,90200Cr 7.27TCr 51TCr 20TCr 2,49900Cr 19TCr 19TCr 8,10300Cr P/E 2026 *
35.1x
P/E 2027 * 26.9x
Enterprise Value 4.75TCr 4.17TCr 3.92TCr 3.59TCr 6.7TCr 4,55400Cr 6.75TCr 47TCr 18TCr 2,32200Cr 18TCr 17TCr 7,52800Cr EV / Sales 2026 *
7.03x
EV / Sales 2027 * 6.19x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day-2.61%
1 week-2.88%
Current month-4.46%
1 month-4.19%
3 months-0.28%
6 months+5.71%
Current year+1.71%
1 week 86.34
Extreme 86.335
89.66
1 month 83.81
Extreme 83.81
92.95
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 11/05/2023
Director of Finance/CFO 43 29/05/2026
Chief Tech/Sci/R&D Officer 51 01/09/2025
Director TitleAgeSince
Chairman 69 07/05/2024
Director/Board Member 62 10/02/2015
Director/Board Member 58 11/05/2023
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Tax

Executive/Senior Manager

-568 0.0001%
13/09/26 Tax

Controller/Auditor

-253 0.0000%
11/09/26 Tax

Executive/Senior Manager

-398 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.62%-2.88%+16.27%+24.83% 5.12TCr
0.00%+1.55%+40.17%+30.22% 24TCr
-0.14%+5.92%+16.33%-12.43% 16TCr
-1.22%+3.91%-11.28%+35.46% 14TCr
-1.54%+0.99%-54.61%-17.57% 6.51TCr
-0.61%-3.02%-20.99%-21.27% 4.77TCr
-1.90%+7.01%+30.59%+46.92% 4.72TCr
-1.02%+0.77%+40.99%+55.69% 4.18TCr
+2.04%+10.29%+154.10%+92.14% 3.74TCr
-0.01%-2.52%-19.27%+60.89% 3.18TCr
Average -0.72%+4.45%+19.23%+29.49% 8.63TCr
Weighted average by Cap. -0.60%+4.35%+17.72%+22.59%

Financials

2026 *2027 *
Net sales 675.95Cr 593.28Cr 557.69Cr 509.88Cr 952.78Cr 65TCr 959.85Cr 6.7TCr 2.6TCr 33TCr 2.54TCr 2.48TCr 1,07000Cr 742.89Cr 652.03Cr 612.91Cr 560.37Cr 1.05TCr 71TCr 1.05TCr 7.36TCr 2.85TCr 36TCr 2.79TCr 2.73TCr 1,17600Cr
Net income 143.52Cr 125.96Cr 118.41Cr 108.25Cr 202.29Cr 14TCr 203.79Cr 1.42TCr 551.36Cr 7.01TCr 538.94Cr 527.13Cr 23TCr 189.67Cr 166.47Cr 156.48Cr 143.07Cr 267.34Cr 18TCr 269.33Cr 1.88TCr 728.67Cr 9.26TCr 712.26Cr 696.65Cr 30TCr
Net Debt -363.09Cr -318.68Cr -299.56Cr -273.88Cr -511.79Cr -35TCr -515.58Cr -3.6TCr -1.39TCr -18TCr -1.36TCr -1.33TCr -57TCr -519.47Cr -455.94Cr -428.58Cr -391.84Cr -732.21Cr -50TCr -737.64Cr -5.15TCr -2TCr -25TCr -1.95TCr -1.91TCr -82TCr
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
24/26/24 $86.67 -2.38% 15,82,926
22/26/22 $88.78 +0.50% 35,34,102
21/26/21 $88.34 +0.09% 33,47,115
18/26/18 $88.26 +0.01% 42,58,353
17/26/17 $88.25 -1.15% 38,80,110
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
88.78USD
Average target price
100.96USD
Spread / Average Target
+13.72%

Quarterly revenue - Rate of surprise